Theory Paper IDrNB Cardiology – Theory Notes

PRE OP EVALUATION OF TOF

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IINTRODUCTION / DEFINITION

  • Definition: Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect. It stems from a singular morphogenetic anomaly: the anterocephalic deviation of the infundibular septum.
  • The Tetrad: This single deviation produces four anatomical hallmarks: a large, malaligned subaortic Ventricular Septal Defect (VSD), overriding of the aorta, Right Ventricular Outflow Tract (RVOT) obstruction (multilevel: infundibular, valvular, or supravalvular), and consequent Right Ventricular Hypertrophy (RVH).
  • Goal of Pre-Operative Assessment: To systematically map the RVOT, evaluate the pulmonary arterial tree, rule out dangerous coronary anomalies, and optimize the patient’s hemodynamic and hematologic status prior to surgical intervention.

IICLINICAL FEATURES & RISK STRATIFICATION

  • Clinical Presentation: Ranges from asymptomatic murmurs in the neonatal period (“pink tet”) to profound cyanosis, clubbing, and severe exertional dyspnea in older infants.
  • Auscultation: A loud, harsh crescendo-decrescendo systolic ejection murmur at the left upper sternal border. Crucial Exam Point: The murmur originates from the RVOT obstruction, not the VSD (which is large and unrestrictive). The shorter and softer the murmur, the more severe the obstruction and right-to-left shunting.
  • Pre-Operative Risk Stratification:
    • Anatomical High-Risk Features: Anomalous Left Anterior Descending (LAD) artery crossing the RVOT (5–9% prevalence), hypoplastic branch pulmonary arteries (Nakata Index < 150 mm²/m²), and the presence of Major Aortopulmonary Collateral Arteries (MAPCAs).
    • Syndromic Risk (DiGeorge Syndrome): 22q11.2 microdeletion is present in ~15% of TOF patients. It mandates pre-operative screening as it is associated with thymic aplasia (immune deficiency) and profound post-operative hypocalcemia.

IIIBASIC INVESTIGATIONS (ECG, CXR, LABS)

  • 12-Lead Electrocardiogram (ECG):
    • Findings: Right Axis Deviation (RAD) and prominent Right Ventricular Hypertrophy (RVH). Evidenced by tall R waves in V1, deep S waves in V5/V6, and a positive T wave in V1 after 3 days of age (a reliable sign of systemic RV pressure). Right Atrial Enlargement (RAE) may present as peaked P waves in lead II.
  • Chest X-Ray (CXR):
    • Findings: Classic “Coeur en Sabot” (Boot-shaped heart). Caused by the uplifted cardiac apex (due to RVH) and a concave main pulmonary artery segment.
    • Pulmonary Vasculature: Decreased pulmonary vascular markings (oligemia) due to restricted pulmonary blood flow.
    • Aortic Arch: Right-sided aortic arch is visible in 25% of patients (crucial for planning palliative shunt laterality).
  • Laboratory Investigations:
    • Complete Blood Count (CBC): Essential to evaluate for secondary polycythemia. A normal or low hemoglobin in a cyanotic TOF patient indicates severe relative iron deficiency anemia, which drastically increases the risk of hyperviscosity syndrome and stroke.
    • Metabolic Panel: Baseline renal function and serum calcium (anticipating DiGeorge syndrome hypocalcemia).
    • Genetic Testing: Microarray analysis for the 22q11.2 deletion is standard pre-operative care.

IVADVANCED DIAGNOSTIC ALGORITHM (ECHO, CT, CMR, CATH)

  • Transthoracic Echocardiography (TTE) (Class I):
    • Primary Modality: Defines VSD size and exact degree of aortic override (< 50% for TOF).
    • Annular Sizing: Measures the Pulmonary Valve (PV) annulus diameter to calculate the Z-score. A Z-score of < -3 or -4 strongly predicts the surgical necessity of a Transannular Patch (TAP).
  • Computed Tomography Angiography (CTA) (Class I/IIa):
    • Current Status: The gold standard for pre-operative anatomical mapping. Exquisitely delineates anomalous coronaries crossing the RVOT (preventing fatal surgical transection), calculates the true Nakata Index for distal branch pulmonary arteries, and maps MAPCAs.
  • Diagnostic Cardiac Catheterization (Class IIa/IIb):
    • Current Status: Routine use is obsolete. Strictly reserved for mapping complex MAPCAs invisible on CTA or measuring exact Pulmonary Vascular Resistance (PVR) in delayed, older presentations.

VMEDICAL MANAGEMENT & PHARMACOTHERAPY

  • Hypercyanotic (“Tet”) Spell Management:
    • Immediate Posture: Knee-to-chest position (increases systemic vascular resistance [SVR], forcing blood across the RVOT) and 100% supplemental Oxygen.
    • Morphine Sulfate: 0.1 to 0.2 mg/kg IV or SC. Depresses the respiratory center to break the hyperpnea cycle.
    • IV Fluid Bolus: 15 to 20 mL/kg of isotonic crystalloid to rapidly increase RV preload and physically distend the RVOT.
    • Beta-Blockers (Class I): Esmolol 0.5 mg/kg IV slow bolus over 1 minute (followed by 50 mcg/kg/min infusion), or Propranolol 0.1 mg/kg IV slow push. Directly relieves dynamic infundibular muscle spasm.
    • Vasopressors (Refractory): Phenylephrine 5 to 10 mcg/kg IV bolus, followed by 0.1 to 0.5 mcg/kg/min infusion to maximally drive up SVR.
  • Pre-Operative Optimization: Oral iron supplementation (Ferrous Sulfate 3-6 mg/kg/day of elemental iron) if relative anemia is detected to improve red blood cell deformability.

VIINTERVENTIONAL & SURGICAL MANAGEMENT

  • Elective Complete Primary Repair (Class I):
    • Timing: Optimally performed between 3 to 6 months of age. Includes VSD patch closure and relief of RVOT obstruction (via infundibular muscle resection and, if necessary, a transannular patch).
  • Pre-Operative Palliation (Class IIa):
    • Indications: Symptomatic neonates with unfavorable anatomy (severe pulmonary hypoplasia, extreme prematurity) unable to tolerate primary repair.
    • Current Paradigm: Percutaneous RVOT stenting is rapidly replacing the surgical modified Blalock-Taussig-Thomas (mBTT) shunt as it promotes highly symmetrical branch pulmonary artery growth.

VIIMANAGEMENT OF COMPLICATIONS

  • Peri-Operative Arrhythmias: Junctional Ectopic Tachycardia (JET) is a classic post-operative complication following VSD patch suturing near the AV node. Managed with core cooling (mild hypothermia 34-35°C), minimizing inotropes, and Amiodarone infusion (5 mg/kg over 1 hour).
  • Restrictive Right Ventricular Physiology: Post-operative RV diastolic dysfunction causing low cardiac output. Managed by prolonging mechanical ventilation, maintaining high central venous pressures (CVP 12-15 mmHg) to drive pulmonary flow, and judicious use of Milrinone (0.5 mcg/kg/min).

VIIILIFESTYLE, FOLLOW-UP & PROGNOSIS

  • Endocarditis Prophylaxis: Required for 6 months post-complete repair, or lifelong if residual defects remain adjacent to prosthetic patch material.
  • Long-Term Surveillance: All patients face the inevitable consequence of severe Pulmonary Regurgitation (PR) if a transannular patch was used. Annual Echocardiography and serial CMR (starting in late childhood/adolescence) are mandated to track RV End-Diastolic Volume Index (RVEDVi) to appropriately time Percutaneous Pulmonary Valve Implantation (PPVI) before irreversible RV failure occurs.

IXCURRENT STATUS, EVIDENCE & PARADIGM SHIFTS (2025 UPDATES)

  • The Valve-Sparing Paradigm: Aggressive shift away from routine transannular patches. Advanced intraoperative balloon dilation and meticulous infundibular sparing techniques now allow preservation of native pulmonary valves even with borderline pre-op Z-scores (-2.5), significantly delaying the onset of PR and the need for future re-intervention.
  • Advanced 3D Modeling: High-resolution pre-operative CTA datasets are now routinely utilized to 3D-print patient-specific cardiac models in complex TOF variants (e.g., crossing coronaries). This enables the surgical team to physically pre-plan the specific geometry of the RVOT baffle, helping to shorten operative and bypass times.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.